Diabetologia

, Volume 43, Issue 2, pp 210–217

Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes

Authors

  • P. Söhnlein
    • Dept of Orthopaedic Surgery University of Heidelberg, Germany
  • M. Müller
    • Department of Internal Medicine 1, University of Ulm, Ulm, Germany
  • K. Syren
    • Department of Internal Medicine 1, University of Ulm, Ulm, Germany
  • U. Hartmann
    • Department of Internal Medicine 1, University of Ulm, Ulm, Germany
  • B. O. Böhm
    • Department of Internal Medicine 1, University of Ulm, Ulm, Germany
  • H. M. Meinck
    • Department of Clinical Neurology, University of Heidelberg, Germany
  • M. Knip
    • Medical School University of Tampere and Deptartment of Paediatrics, Tampere University Hospital, Tampere, Finland
  • H. K. Akerblom
    • Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
  • W. Richter
    • Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
  • The Childhood Diabetes in Finland Study Group
Article

DOI: 10.1007/s001250050031

Cite this article as:
Söhnlein, P., Müller, M., Syren, K. et al. Diabetologia (2000) 43: 210. doi:10.1007/s001250050031

Abstract

Aims/hypothesis. The aim of this study was to analyse the conformational and linear epitope profiles of glutamic acid decarboxylase antibody (GAD65-ab)-positive sera to find disease-specific epitope profiles and to study, whether GAD65-ab epitope recognition changes or spreads during the prediabetic period and, thus, can provide markers to differentiate early from later stages of progression to diabetes.¶Methods. Sera from subjects before (n = 21), at onset (n = 44), or at increased risk of Type I (insulin-dependent) diabetes mellitus (n = 20) and from patients with stiff-man syndrome (SMS, n = 18) or polyendocrine autoimmune syndrome (PAS, n = 21) were analysed for conformational and linear GAD65 epitope recognition by an immunohistochemical blocking test based on human monoclonal GAD65-ab (MICA 1–10) and western blotting of a GAD65 epitope-cDNA-library.¶Results. A redundant reactivity of many GAD65-ab positive sera to three major conformational (EP-1, EP-2, EP-3) and two dominant linear epitope clusters (amino acid 1–124 and 535–585) was observed in diabetes, polyendocrine autoimmune syndrome and stiff-man syndrome and no disease-specific epitopes or epitope-profiles were detected. Epitope recognition broadened with higher titres and with the vulnerability of patients to acquire additional autoimmune diseases apart from diabetes. Low GAD65-ab serum titres ( < 1200 arbitrary units) and EP-1 recognition in the absence of EP-2 binding characterised the early immune response. Changing epitope profiles combined stable recognition of EP-1 with gain or loss of reactivity to C-terminal epitopes during follow-up.¶Conclusion/interpretation. A maturing autoantibody response, which could spread from EP-1-recognition to other regions of GAD65, resulted in titre-related rather than disease-specific epitope profiles which were not sufficient to predict whether GAD65-ab positive subjects will progress to Type I diabetes, autoimmune polyendocrine syndrome or stiff-man syndrome. [Diabetologia (2000) 43: 210–217]

Keywords Glutamate decarboxylase, autoantibodies, epitope-specificity, Type I diabetes, polyendocrine autoimmune syndrome, stiff-man syndrome, prediabetes.

Copyright information

© Springer-Verlag Berlin Heidelberg 2000